Antimicrobial susceptibility and the in vitro postantibiotic effects of vancomycin and ciprofloxacin against Bacillus cereus isolates

References

• Notermans S, Dufrenne J, Teunis P, Beumer R, Giffel M, Weem P. A risk assessment study of Bacillus cereus present in pasteurized milk. Food Microbiol. 1997;14(2):143–51.
   Web of Science ®Google Scholar
• Kiel JL, Parker JE, Holwitt EA, McCreary RP, Andrews CJ, De Los Santos A, et al. Geographical distribution of genotypic and phenotypic markers among Bacillus anthracis isolates and related species by historical movement and horizontal transfer. Folia Microbiol. 2008;53(6):472–8.
   PubMed Web of Science ®Google Scholar
• Adler A, Gottesman G, Dolfin T, Arnon S, Regev R, Bauer S, et al. Bacillus species sepsis in the neonatal intensive care unit. J Infect. 2005;51(5):390–5.
   PubMed Web of Science ®Google Scholar
• Dubouix A, Bonnet E, Alvarez M, Bensafi H, Archambaud M, Chaminade B, et al. Bacillus cereus infections in traumatology-orthopaedics department: retrospective investigation and improvement of healthcare practices. J Infect. 2005;50(1):22–30.
   PubMed Web of Science ®Google Scholar
• Ginsburg AS, Salazar LG, True LD, Disis ML. Fatal Bacillus cereus sepsis following resolving neutropenic enterocolitis during the treatment of acute leukemia. Am J Hematol. 2003;72(3):204–8.
   PubMed Web of Science ®Google Scholar
• Katsuya H, Takata T, Ishikawa T, Sasaki H, Ishitsuka K, Takamatsu Y, et al. A patient with acute myeloid leukemia who developed fatal pneumonia caused by carbapenem-resistant Bacillus cereus. J Infect Chemother. 2009;15(1):39–41.
   PubMed Web of Science ®Google Scholar
• Savini V, Favaro M, Fontana C, Catavitello C, Balbinot A, Talia M, et al. Bacillus cereus heteroresistant to carbapenems in a cancer patient. J Hosp Infect. 2009;71(3):288–90.
   PubMed Web of Science ®Google Scholar
• Savini V, Berhardt LV. Bacillus cereus pneumonia. Advances in medicine and biology. 67. Italy: Nova Science Publisher Inc city; 2013; p.16.
   Google Scholar
• Bottone EJ. Bacillus cereus, a volatile human pathogen. Clin Microbiol Rev. 2010;23(2):382–98.
   PubMed Web of Science ®Google Scholar
• Strauss R, Mueller A, Wehler M, Neureiter D, Fischer E, Gramatzki M, et al. Pseudomembranous tracheobronchitis due to Bacillus cereus. Clin Infect Dis. 2001;33(5):e39–e41.
   PubMed Web of Science ®Google Scholar
• Hanberger H, Nilsson LE, Kihlstrom E, Maller R. Postantibiotic effect of β-lactam antibiotics on Escherichia coli by bioluminescence assay of bacterial ATP. Antimicrob Agents Chemother. 1990;34(1):102–6.
   PubMed Web of Science ®Google Scholar
• Munckhof WJ, Giles C, Turnidge JD. Post-antibiotic growth suppression of linezolid against Gram-positive bacteria. J Antimicrob Chemother. 2001;47(6):879–83.
   PubMed Web of Science ®Google Scholar
• International Standard Organization: Microbiology of food and animal feeding stuffs – horizontal method for the enumeration of presumptive Bacillus cereus – colony-count technique at 30°C. Brussels, Belgium: 7 [ISO document] International Standard Organization; 2004.
   Google Scholar
• Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing; 23rd informational supplement. Wayne, PA: [CLSI document M100-S23] Clinical and Laboratory Standards Institute; 2013; p. 70–86.
   Google Scholar
• Clinical and Laboratory Standards Institute: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 9th edn. Wayne, PA: Clinical and Laboratory Standards Institute; 2012; p. 10–9. 48–57; 146–61 [CLSI document MO7-A9, 32].
   Google Scholar
• Bedenić B, Vraneš J, Sviben M, Beader N, Kalenić S. Postantibiotic and post-beta-lactamase inhibitor effect of carbapenems combined with EDTA against Pseudomonas aeruginosa strains producing VIM-metallo beta-lactamases. Chemother. 2004;54(3):188–93.
   Google Scholar
• Murbach V, Dhoyen N, Kinger H, Jehl F. Evidence for a true post-β-lactamase-inhibitor effect of clavulanic acid against Klebsiella pneumoniae and Haemophilus influenzae. Clin Microbiol Infect. 2008;7(12):661–5.
   Web of Science ®Google Scholar
• Giamarellos-Bourboulis EJ, Kentepozidis N, Antonopoulou A, Plachouras D, Tsaganos T, Giamarellou H. Postantibiotic effect of antimicrobial combinations on multidrug-resistant Pseudomonas aeruginosa. Diagn Microbiol Infect Dis. 2001;51(2):113–7.
   Web of Science ®Google Scholar
• Fritze D, Claus D. Media for Bacillus spp. and related genera relevant to food. In: Corry JEL, Curtis GDW, Baird RM, editors. Handbook of culture media for food microbiology. 2nd edn. New York: Elsevier Science; 2003; p. 61–78.
   Google Scholar
• Mazoua S, Chauveheid E. Aerobic spore-forming bacteria for assessing quality of drinking water produced from surface water. Water Res. 2005;39(20):5186–98.
   PubMed Web of Science ®Google Scholar
• Louie A, VanScoy BD, Heine HS III, Weiguo L, Abshire T, Holman K, et al. Differential effects of linezolid and ciprofloxacin on toxin production by Bacillus anthracis in an in vitro pharmacodynamic system. Antimicrob Agents Chemother. 2012;56(1):513–7.
   PubMed Web of Science ®Google Scholar
• Lavigne JP, Bonnet R, Charachon SM, Jourdan J, Caillon J, Sotto A. Post-antibiotic and post-β-lactamase inhibitor effects of ceftazidime plus sulbactam on extended-spectrum-β-lactamase producing Gram-negative bacteria. J Antimicrob Chemother. 2004;53(4):616–9.
   PubMed Web of Science ®Google Scholar
• Mohammed MJ, Marston CK, Popovic T, Weyant RS, Tenover FC. Antimicrobial susceptibility testing of Bacillus anthracis: comparison of results obtained by using the National Committee for Clinical Laboratory Standards broth microdilution reference and Etest agar gradient diffusion methods. J Clin Microbiol. 2002;40(6):1902–7.
   PubMed Web of Science ®Google Scholar
• Tascini C, Flammini S, Leonildi A, Ciullo I, Tagliaferri E, Menichetti F. Comparison of teicoplanin and vancomycin in vitro activity on clinical isolates of Staphylococcus aureus. J Chemother. 2012;24(4):187–90.
   PubMed Web of Science ®Google Scholar
• Horii T, Notake S, Tamai K, Yanagisawa H. Bacillus cereus from blood cultures: virulence genes, antimicrobial susceptibility and risk factors for blood stream infection. FEMS Immunol Med Microbiol. 2011;63(2):202–9.
   PubMedGoogle Scholar
• Ozkocaman V, Ozcelik T, Ali R, Ozkalemkas F, Ozkan A, Ozakin C, et al. Bacillus spp. among hospitalized patients with haematological malignancies: clinical features, epidemics and outcomes. J Hosp Infect. 2006;64(2):169–76.
   PubMed Web of Science ®Google Scholar
• Turnbull PCB, Sirianni NM, LeBron CL, Samaan MN, Sutton FN, Reyes AE, et al. MICs of selected antibiotics for Bacillus anthracis, Bacillus cereus, Bacillus thuringiensis, and Bacillus mycoides from a range of clinical and environmental sources as determined by Etest. J Clin Microbiol. 2004;42(8):3626–34.
   PubMed Web of Science ®Google Scholar
• Athamna A, Athamna M, Medlej B, Bast DJ, Rubinstein E. In vitro post-antibiotic effect of fluoroquinolones, macrolides, β-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis. J Antimicrob Chemother. 2004;53(4):609–15.
   PubMed Web of Science ®Google Scholar
• Van Zanten ARH, Polderman KH, van Geijlswijk IM, van der Meer GYG, Schouten MA, Girbes ARJ. Ciprofloxacin pharmacokinetics in critically ill patients: a prospective cohort study. J Crit Care. 2008;23(3):422–30.
   PubMed Web of Science ®Google Scholar
• D'Espine M, Bellido F, Pechère JC, Auckenthaler R, Rohner P, Lew D, et al. Serum levels of ciprofloxacin after single oral doses in patients with septicemia. Eur J Clin Microbiol Infect Dis. 1989;8(12):1019–23.
   PubMed Web of Science ®Google Scholar
• Yao JDC, Moellering RCJr. Antibacterial agents. In: Murray PR, Baron JH, Landry ML, Pfaller MA, editors. itors. Manual of clinical microbiology. 9th edn. Herndon: ASM Press; 2007; p. 1077–13.
   Google Scholar
• Berlanga M, Montero MT, Hernández-Borrell J, Viñas M. Influence of the cell wall on ciprofloxacin susceptibility in selected wild-type Gram-negative and Gram-positive bacteria. Intern J Antimicrob Agents. 2004;23(6):627–30.
   PubMed Web of Science ®Google Scholar
• Grohs P, Kitzis M-D, Gutma L. In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus. Agents Chemother. 2003;47(1):418–20.
   PubMed Web of Science ®Google Scholar
• Daniel RA, Errington J. Control of cell morphogenesis in bacteria: two distinct ways to make a rod-shaped cell. Cell. 2003;113(6):767–76.
   PubMed Web of Science ®Google Scholar
• Tiyanont K, Doan T, Lazarus MB, Xiao Fang X, Rudner DZ, Walker S. Imaging peptidoglycan biosynthesis in Bacillus subtilis with fluorescent antibiotics. Proc Natl Acad Sci USA. 2006;103(29):11033–38.
   PubMed Web of Science ®Google Scholar
• Aldred KJ, McPherson SA, Wang P, Kerns RJ, Graves DE, Turnbough CL Jr, et al. Drug interactions with Bacillus anthracis topoisomerase IV: biochemical basis for quinolone action and resistance. Biochemistry. 2012;51(1):370–81.
   PubMed Web of Science ®Google Scholar
• Citron DM, Appleman MD. In vitro activities of daptomycin, ciprofloxacin, and other antimicrobial agents against the cells and spores of clinical isolates of Bacillus species. J Clin Microbiol. 2006;44(10):3814–8.
   PubMed Web of Science ®Google Scholar
• Tourasse NJ, Helgason E, Økstad OA, Hegna IK, Kolstø AB. The Bacillus cereus group: novel aspects of population structure and genome dynamics. J Appl Microbiol. 2006;101(3):579–93.
   PubMed Web of Science ®Google Scholar
• Deziel MR, Heine H, Louie A, Kao M, Byrne WR, Basset J, et al. Effective antimicrobial regimens for use in humans for therapy of Bacillus anthracis infections and postexposure prophylaxis. Antimicrob Agents Chemother. 2005;49(12):5099–06.
   PubMed Web of Science ®Google Scholar
• Swaney SM, Aoki H, Ganoza MC, Shinabarger DL. The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria. Antimicrob Agents Chemother. 1998;42(12):3251–5.
   PubMed Web of Science ®Google Scholar
• Smith RP, Baltch AL, Michelsen PB, Ritz WJ, Alteri R. Use of the microbial growth curve in postantibiotic effect studies of Legionella pneumophila. Antimicrob Agents Chemother. 2003;47(3):1081–7.
   PubMed Web of Science ®Google Scholar